CT
BLFS icon

Colonial Trust’s BioLife Solutions BLFS Stock Holding History

Colonial Trust’s Portfolio BLFS Stock Details BLFS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q3 		– Sell
-95
Closed -$2.15K – 953
2023
Q2 		$2.15K Hold
95
– – ﹤0.01% 884
2023
Q1 		$1.97K Hold
95
– – ﹤0.01% 856
2022
Q4 		$1.72K Buy
+95
New +$1.96K ﹤0.01% 864

Other funds holding BLFS

CC
Casdin Capital New York $1.32B AUM 76.62% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
PWAM
Park West Asset Management San Francisco, California $1.18B AUM 47.25% 1-Year Est. Return
FAM
Fred Alger Management New York $22.8B AUM 64.63% 1-Year Est. Return
GCM
Geneva Capital Management Milwaukee, Wisconsin $4.71B AUM 6.32% 1-Year Est. Return
PCM
Palisade Capital Management Fort Lee, New Jersey $3B AUM 14% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
GIM
Granahan Investment Management Waltham, Massachusetts $2.07B AUM 56.45% 1-Year Est. Return

Colonial Trust's BLFS Position: Q3 2023 in Review

Colonial Trust sold out of BioLife Solutions (BLFS) in Q3 2023, closing a stake of 95 shares — an estimated $2.15K sold.

Colonial Trust first reported a position in BLFS in Q4 2022 and held it in 3 quarters. The position peaked at $2.15K in Q2 2023. 153 funds tracked by Wall St. Rank hold BLFS as of Q3 2023.

  • Colonial Trust reported no remaining BioLife Solutions position as of Q3 2023 after selling out during the quarter.
  • Colonial Trust sold 95 BioLife Solutions shares in Q3 2023, an estimated $2.15K.
  • Colonial Trust first reported a position in BioLife Solutions in Q4 2022 and held it in 3 quarters.
  • Colonial Trust's BioLife Solutions position peaked at $2.15K in Q2 2023.
  • 153 funds tracked by Wall St. Rank held BioLife Solutions as of Q3 2023.

Based on Colonial Trust's 13F filing for Q3 2023, filed 13 Nov 2023.